Top Research Publications: January & February 2025

In February 2025, DOIM Faculty had over 70 papers reported as published. Of these publications, 57% of papers were in the top 10% of journals, and 6% were in the top 1% of journals.

• Pulsatile Organ Perfusion in Heart Transplantation: A Report From the OCS Heart Perfusion Registry. Josef Stehlik (Cardiovascular) (first author) – Circulation; CiteScore 45.7; Top 1% of Cardiology and Cardiovascular Medicine (Altmetrics Score 2)
• Gastrointestinal tissue eosinophil quantification in healthy adult volunteers. Tursun Trapov, Amiko Uchida, Maria Pletneva, and Kathryn Peterson (Gastroenterology) – Gastroenterology; CiteScore 45.6; Top 3% of Gastroenterology Journals
• Pseudomonas aeruginosa infection induces intragraft lymphocytotoxicity that triggers lung transplant antibody-mediated rejection. Ramsey Hachem (Pulmonary) (middle author) – Science Translational Medicine; CiteScore 26.7; Top 2% of General Medicine Journals (Altmetrics Score 63)
• Developing approaches to incorporate donor-lung computed tomography images into machine learning models to predict severe primary graft dysfunction after lung transplantation. Ramsey Hachem (Pulmonary) (middle author) - American Journal of Transplantation; CiteScore 18.7; Top 2% of Pharmacology (medical) journals
• Real-world use of tafasitamab preceding CD19-directed chimeric antigen receptor T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma. Narendranth Epperla (Hematology) (1st author) - Biomarker Research; Journal CiteScore 15.8; Top 5% of Clinical Biochemistry Journals
• A Framework to Optimize Primary Care of Older Surgical Patients: A Qualitative Study of Geriatricians. Roxanne Weiss and Mark Supiano (Geriatrics) (middle authors) – JAMA Network Open; CiteScore 16; Top 5% of General Medicine Journals (Altmetric Score: 12; Covered by 1 news outlet)
• The Association Between Thyrotropin and Clinically Relevant Depression: A Retrospective Cross-Sectional Study. Vishnu Sundaresh (Endocrinology) (last author) – Thyroid; Journal CiteScore 12.3; Top 10% of Endocrinology Journals
• Adherence to self-monitoring and behavioral goals is associated with improved weight loss in an mHealth randomized-controlled trial. Molly Conroy (General Internal Medicine) (middle author) - Obesity; Journal CiteScore 11.7; Top 5% of Medicine Journals.
• Turner syndrome: fertility, familial clustering, and cancer risk. Kristina Allen-Brady (Epidemiology) (first author) and Bonita Austin and Corrine Welt (Endocrinology) (Welt – last author) - Human Reproduction; Journal CiteScore 10.9, Top 4% of Obstetrics and Gynecology Journals (Altmetrics Score: 1)
• Comparative effectiveness of insulin glargine, glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in veterans with type 2 diabetes. Jincheng Shen, McKenna Nevers, Tom Greene (Epidemiology), Stavros Drakos (Cardiovascular) and Amara Sarwal, Sydney Hartsell, Guo Wei, Augustine Takyi, Nihariko Katkam, Robert Boucher, and Srini Beddu (Nephrology) (Shen – first author; Beddu – last author) - Diabetes, Obesity and Metabolism; Journal CiteScore 10.9; Top 10% of Internal Medicine Journals
• EUS-guided cystocystostomy for management of noncommunicating peripancreatic fluid collections. Emily Fellows, David Jonason, Jason DuBroff, John Morris, and Christopher Ko (Gastroenterology) (Fellows – first author; Ko – last author) - Gastrointestinal Endoscopy; CiteScore 10.3; Top 10% of Gastroenterology Journals
• Genomic biomarkers of survival in patients with metastatic hormone-sensitive prostate cancer undergoing intensified androgen deprivation therapy. Georges Gebrael, Nicolas Sayegh, Chadi Chehade, Arshit Narang, Beverly Chigarira, Nishita Tripathi, Ayana Srivastava, Clara Tander, Diya Garg, Richard Ji, Benjamin Maughan, Neeraj Agarwal (Oncology) (Georges Gebrael – first author; Neeraj Agarwal – last author) - Prostate Cancer and Prostatic Diseases; CiteScore 10; Top 5% of Urology Journals
• Multi-gene risk-score for prediction of clinical outcomes in treatment-naïve metastatic castrate resistant prostate cancer. Brayden Fairbourn and Manish Kohli (Oncology) (last author) - JNCI Cancer Spectrum (New Journal); CiteScore 7.7; Top 25% of Oncology journals (Altmetric Score: 1) 

CiteScore Calculation Can Be Found Here